ASG Eye Hospital and Bavishi Eye Hospitals announce partnership to expand eye care in Gujarat

IMT News Desk
IMT News Desk
· 2 min read

The collaboration will also expand services to new locations, including Nehru Nagar, Relief Road, Isanpur, and a flagship Centre of Excellence on SG Highway

ASG Eye Hospital, one of India’s fastest-growing super-specialty eye-care chains with 175+ hospitals and 200 vision centres across 87 cities, announced a strategic partnership with Bavishi Eye Hospitals, a pioneer in ophthalmology with six decades of trusted care in Gujarat. The Chief Minister of Gujarat, Bhupendrabhai Patel was the Guest of Honour and hailed the partnership as a prestigious milestone in advancing eye care in the state.

These centres will be manned around the clock for all specialities and sub-specialities for ophthalmology under one roof, which include spectacle correction or LASIK, retina services, pediatric ophthalmology, Myopia clinic,  Amblyopia correction, Ocular oncology, Oculoplasty and facial Aesthetics, glaucoma management, corneal transplantation, along with many more.

These initiatives will be headed by

  • Dr Darshin Bavishi with 32+ years of experience specializing in comprehensive eye care including cataract surgery, refractive procedures, glaucoma management, and corneal transplantation.
  • Dr Alap Bavishi with 8+ years of specialising in cataract surgery, refractive vision correction (LASIK, SMILE), glaucoma care, and comprehensive eye health.
  • Dr Bhavik Panchal: 14 + years of experience, practicing ophthalmologist specializing in vitroretinal surgeries, uveitis disorders, retinopathy of prematurity (ROP) and Cataract. (Ex Director : L.V. Prasad Eye institute).
  • Dr Snehal Ganatra Panchal: 12+ years of experience, specializing in Pediatric Ophthalmologist, Squint and Cataract surgeries.
  • Dr  Bhavya Gokani: 8 + years of experience specializing in Cataract, Refractive vision correction and glaucoma treatment.

Dr Arun Singhvi, Managing Director and CEO, ASG Eye Hospital, said, “The launch in Ahmedabad is another step forward in our mission to make advanced eye care accessible to every community. Partnering with Bavishi allows us to combine their trusted care with our scale and technology, creating a stronger ecosystem of patient-first care across Gujarat.”

Dr Darshin Bavishi, Director, Bavishi Eye Hospitals, added: “Bavishi Eye Hospital has long been a trusted name in Ahmedabad — a hospital that generations of families prefer for its compassionate care, clinical excellence, and lasting relationships. As we celebrate 60 years of service, this partnership marks a new chapter in our journey. ASG shares our values and commitment to excellence, enabling us to reach more patients, enhance outcomes, and build on our legacy with stronger technology and scale.”

The collaboration will also expand services to new locations, including Nehru Nagar, Relief Road, Isanpur, and a flagship Centre of Excellence on SG Highway.

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk